| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,504 |
31,808 |
$2.37M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14,022 |
13,940 |
$946K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,295 |
9,564 |
$786K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,709 |
1,694 |
$162K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,400 |
1,393 |
$118K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,436 |
6,362 |
$62K |
| 31231 |
|
540 |
503 |
$58K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,415 |
1,309 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
495 |
487 |
$47K |
| 99000 |
|
7,637 |
7,032 |
$33K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
949 |
911 |
$32K |
| 99385 |
|
229 |
227 |
$23K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
122 |
114 |
$22K |
| 36415 |
Collection of venous blood by venipuncture |
7,010 |
6,593 |
$18K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
105 |
96 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,253 |
1,239 |
$15K |
| 95024 |
|
102 |
102 |
$14K |
| 99490 |
Ccm add 20min |
1,125 |
1,123 |
$14K |
| 93000 |
|
1,617 |
1,606 |
$14K |
| 99386 |
|
107 |
106 |
$13K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
245 |
245 |
$13K |
| 80053 |
Comprehensive metabolic panel |
1,408 |
1,379 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
904 |
883 |
$11K |
| 90674 |
|
379 |
378 |
$11K |
| 99441 |
|
647 |
624 |
$10K |
| 90756 |
|
405 |
401 |
$10K |
| Q4177 |
Floweramnioflo, 0.1 cc |
15 |
14 |
$9K |
| 99215 |
Prolong outpt/office vis |
96 |
91 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
512 |
501 |
$9K |
| 90686 |
|
417 |
413 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
620 |
451 |
$8K |
| 81002 |
|
2,918 |
2,850 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
573 |
557 |
$7K |
| 82962 |
|
2,789 |
2,486 |
$7K |
| 95117 |
|
1,013 |
398 |
$6K |
| G0008 |
Administration of influenza virus vaccine |
626 |
623 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
254 |
249 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
780 |
761 |
$5K |
| 72100 |
|
255 |
252 |
$5K |
| 70486 |
|
63 |
61 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
650 |
630 |
$4K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,560 |
2,058 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,414 |
3,076 |
$4K |
| 69210 |
|
192 |
189 |
$4K |
| 0011A |
|
89 |
89 |
$3K |
| 73560 |
|
175 |
137 |
$3K |
| 0012A |
|
71 |
71 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
310 |
292 |
$3K |
| 85027 |
|
402 |
398 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
37 |
37 |
$2K |
| 80061 |
Lipid panel |
325 |
313 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
59 |
59 |
$2K |
| 82607 |
|
282 |
267 |
$2K |
| 99442 |
|
58 |
56 |
$2K |
| 90715 |
|
46 |
45 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
70 |
69 |
$1K |
| 81025 |
|
165 |
161 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
112 |
106 |
$960.82 |
| 20610 |
|
25 |
24 |
$780.27 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
24 |
24 |
$756.39 |
| 20552 |
|
27 |
26 |
$669.35 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
454 |
426 |
$658.45 |
| 86328 |
|
17 |
16 |
$655.40 |
| 72040 |
|
26 |
26 |
$462.61 |
| 99454 |
|
14 |
14 |
$457.03 |
| 73030 |
|
15 |
13 |
$285.60 |
| 99457 |
|
14 |
14 |
$265.09 |
| 81003 |
|
143 |
138 |
$263.24 |
| 99406 |
|
45 |
42 |
$262.57 |
| 73120 |
|
13 |
12 |
$239.46 |
| 94642 |
|
12 |
12 |
$185.75 |
| 96127 |
|
54 |
53 |
$151.63 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
196 |
184 |
$150.34 |
| 81001 |
|
49 |
48 |
$137.86 |
| 92567 |
|
14 |
14 |
$105.56 |
| 84439 |
|
13 |
12 |
$70.04 |
| 82746 |
|
20 |
16 |
$65.52 |
| 84425 |
|
13 |
13 |
$62.76 |
| 82465 |
|
15 |
15 |
$62.35 |
| 99072 |
|
1,071 |
1,017 |
$37.50 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
16 |
15 |
$27.10 |
| 99051 |
|
146 |
145 |
$17.38 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
73 |
71 |
$9.29 |
| 3050F |
|
24 |
24 |
$0.12 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
191 |
187 |
$0.01 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
241 |
222 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
22 |
19 |
$0.00 |
| 97803 |
|
39 |
38 |
$0.00 |
| 3051F |
|
55 |
55 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
108 |
101 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
154 |
151 |
$0.00 |
| 1111F |
|
47 |
41 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
41 |
37 |
$0.00 |
| 3044F |
|
182 |
181 |
$0.00 |
| 91301 |
|
83 |
83 |
$0.00 |
| 1036F |
|
193 |
181 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
13 |
12 |
$0.00 |
| 97802 |
|
13 |
12 |
$0.00 |